Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Dec;120(1):60–64. doi: 10.1038/sj.bjp.0700852

Pharmacologically distinct GABAB receptors that mediate inhibition of GABA and glutamate release in human neocortex

Giambattisa Bonanna *, Anna Fassio *, Giovanna Schmid *, Paolo Severi *, Robery Sala *, Maurizio Raiteri *,*
PMCID: PMC1564334  PMID: 9117099

Abstract

  1. The release of endogenous γ-aminobutyric acid (GABA) and glutamic acid in the human brain has been investigated in synaptosomal preparations from fresh neocortical samples obtained from patients undergoing neurosurgery to reach deeply located tumours.

  2. The basal outflows of GABA and glutamate from superfused synaptosomes were largely increased during depolarization with 15 mM KCl. The K+-evoked overflows of both amino acids were almost totally dependent on the presence of Ca2+ in the superfusion medium.

  3. The GABAB receptor agonist (−)-baclofen (1, 3 or 10 μM) inhibited the overflows of GABA and glutamate in a concentration-dependent manner. The inhibition caused by 10 μM of the agonist ranged from 45–50%.

  4. The effect of three selective GABAB receptor antagonists on the inhibition of the K+-evoked GABA and glutamate overflows elicited by 10 μM (−)-baclofen was investigated. Phaclofen antagonized (by about 50% at 100 μM; almost totally at 300 μM) the effect of (−)-baclofen on GABA overflow but did not modify the inhibition of glutamate release. The effect of (−)-baclofen on the K+-evoked GABA overflow was unaffected by 3-amino-propyl (diethoxymethyl)phosphinic acid (CGP 35348; 10 or 100 μM); however, CGP 35348 (10 or 100 μM) antagonized (−)-baclofen (complete blockade at 100 μM) at the heteroreceptors on glutamatergic terminals. Finally, [3-[[(3,4-dichlorophenyl) methyl]amino]propyl] (diethoxymethyl) phosphinic aid (CGP 52432), 1 μM, blocked the GABAB autoreceptor, but was ineffective at the heteroreceptors. The selectivity of CGP 52432 was lost at 30 μM, as the compound, at this concentration, inhibited completely the (−)-baclofen effect both on GABA and glutamate release.

  5. It is concluded that GABA and glutamate release evoked by depolarization of human neocortex nerve terminals can be affected differentially through pharmacologically distinct GABAB receptors.

Keywords: Human neocortex, GABAB receptor subtypes, GABA release, glutamate release, phaclofen, CGP 35348, CGP 52432

Full Text

The Full Text of this article is available as a PDF (430.6 KB).


Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES